Pharmaceutical & biotechnology
Quality and technology assurance shaped by clinical, development, manufacturing, and enterprise context — from a first quality system through to a mature estate under continuous cloud change.
Industries
Regulated context changes the technology question.
QA4Tech works with regulated organizations and the specialist providers that support them, connecting technical reality with quality and executive accountability.
Perspective
The technology is rarely the hard part. What changes between one organization and the next is who carries the consequence when it is wrong, how much of the system somebody else operates, and what evidence has to exist before anyone will sign.
Organizations we support
Different markets. A shared need for credible assurance.
Engagements are shaped by the organization’s role, the regulated outcome, and the responsibilities it holds — not by a sector label.
Clinical research organizations
Oversight, auditing, validation, and data-integrity support across sponsor, CRO, vendor, and technology boundaries, where the same activity is delegated but the accountability is not.
Medical technology & digital health
Risk-based support for connected products, health platforms, and data flows, including where software is the product and its release cycle is faster than the quality system was designed for.
Software, cloud, data & AI providers
A regulated-industry perspective for providers entering or serving high-accountability markets, and for those being audited by customers who ask questions the sales team cannot answer.
Laboratories & analytical services
Instrument interfaces, chromatography and imaging data, integration practice, and second-person review examined as they actually operate rather than as the SOP describes them.
Investors, acquirers & boards
Independent quality and technical due diligence before a transaction, and plain assessment of exposure, remediation effort, and cost afterwards.
Where you sit
The same system, six different problems.
A sponsor, a CRO, a technology provider, and a laboratory can depend on one platform and hold entirely different exposures. The seat determines what assurance has to prove.
Sponsor or marketing authorization holder
Holds the regulatory accountability whatever it delegates. Needs oversight that would reveal a supplier failure before the supplier reports it — and evidence that the oversight happened.
CRO or service provider
Audited by many customers to many interpretations of the same requirement. Needs one control environment that satisfies all of them, and the evidence to demonstrate it repeatedly.
Technology or AI provider
Sells into a market that will audit the development lifecycle, not the product demo. Needs to know what regulated customers will ask for before the first qualification audit arrives.
Site, laboratory, or manufacturing operation
Where the data is actually created, and where instrument interfaces, transcription, and second-person review either hold or quietly do not.
Quality function
Expected to challenge technical decisions it may not have been trained to interrogate, and to sign for outcomes decided elsewhere in the organization.
Investor, acquirer, or board
Needs quality and technical exposure expressed as risk, remediation effort, and cost — before signature, not during integration.
What regulation changes
Why the same technology needs different evidence here.
Nothing on this list is unique to regulated industry. What is unique is that each one has to be demonstrable to somebody external, years after the decision was made.
- Intended use has to be written down before the system can be judged fit for it
- Change is assessed before it lands, not explained after it breaks something
- Data carries provenance: who, when, what changed, and why
- Delegated activity stays your accountability whatever the contract says
- Records outlive the system that created them, often by many years
- People must be demonstrably competent for the role, not merely present in it
- Every one of the above has to survive an inspection by someone unsympathetic
Regulated domains
Where the work has applied.
The technology questions rhyme across these domains; the evidence expectations, terminology, and inspectors do not. Scope for an engagement is always confirmed against the domain it sits in.
- GCP
- Clinical research: eClinical platforms, data flows between sponsor, CRO, and site, audit trails, and sponsor oversight of everything delegated.
- GMP
- Manufacturing and product quality: computerized systems in production and the laboratory, outsourced activities, and infrastructure supporting them.
- GLP
- Non-clinical safety studies: study data integrity, instrument systems, archives, and the raw data behind a reported result.
- GVP
- Pharmacovigilance: case processing systems, data completeness and timeliness, and the technology behind a reporting obligation.
- GDP
- Distribution: traceability, temperature and condition records, and the systems that hold the distribution chain together.
- Medical devices & IVD
- Software as a medical device and connected products, where the quality system and the release cycle have to coexist.
Domains are listed to show the range of context this work reaches. They are not a claim of equivalent depth in every one, and the relevant regulatory framework for an engagement is confirmed when its scope is agreed.
Across the value chain
Assurance must follow the responsibility.
A sponsor, CRO, technology provider, and regulated user can depend on the same service while holding different responsibilities and seeing different evidence.
QA4Tech examines those interfaces directly — where expectations, data, decisions, and controls pass between organizations, and where each side assumes the other is in control.
- Regulated organizations adopting new technology
- Service providers supporting regulated work
- Data and AI companies entering regulated markets
- Laboratories and sites where regulated data originates
- Leaders aligning quality, technology, clinical, security, and privacy functions
International delivery
Wherever the work actually is.
QA4Tech is based in Germany and works in English with clients and partners internationally, across sponsors, internal functions, suppliers, and specialist partners.
Focused advisory, document review, governance, and specialist analysis across locations and time zones.
Audits, workshops, stakeholder engagement, and critical program activity that need direct access.
A proportionate combination: remote preparation and follow-up around targeted in-person work.
Start a conversation
Bring regulated-industry context to the technology decision.
Discuss the organization, operating model, and assurance outcome you need to address.